NIPH Clinical Trials Search

Basic Information

Recruitment status	completed
Health condition(s) or Problem(s) studied
Date of first enrollment	04/03/2020
Target sample size	100
Countries of recruitment	Asia except Japan,Japan,North America,South America,Europe
Study type	Interventional
Intervention(s)	investigational material(s) Generic name etc : INN of investigational material : aflibercept Therapeutic category code : 131 Agents for ophthalmic use Dosage and Administration for Investigational material : control material(s) Generic name etc : INN of investigational material : - Therapeutic category code : --- Other Dosage and Administration for Investigational material :

Outcome(s)

Primary Outcome	efficacy safety
Secondary Outcome	safety efficacy

Key inclusion & exclusion criteria

Age minimum	Not applicable
Age maximum	<= 13month old
Gender	Both
Include criteria
Exclude criteria